54325 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 06
00:29 UTC
|
EXPD
Expeditors International of Washington
|
↑ Upgrade | Brian Ossenbeck ★★★☆☆ #1815 | Underweight→ Neutral | $200.00 |
|
Aug 06
00:29 UTC
|
ELF
e.l.f. Beauty
|
↑ Upgrade | Cristian Rios not yet tracked | Market Perform→ Outperform | $60.00→ $113.00+88.3% |
|
Aug 06
00:29 UTC
|
DLR
Digital Realty Trust
|
↑ Upgrade | Eric Luebchow ★★☆☆☆ #2766 | Overweight→ Buy | |
|
Aug 06
00:29 UTC
|
DLR
Digital Realty Trust
|
↑ Upgrade | Marie Ferguson ★★★★☆ #964 | Hold→ Buy | $212.00 |
|
Aug 06
00:29 UTC
|
CRM
Salesforce
|
↑ Upgrade | firm only | Hold→ Buy | |
|
Aug 06
00:29 UTC
|
CPNG
Coupang
|
↑ Upgrade | firm only | Hold→ Buy | $21.50 |
|
Aug 06
00:29 UTC
|
BTDR
Bitdeer Technologies Group
|
↑ Upgrade | Brett Knoblauch ★☆☆☆☆ #3220 | Neutral→ Overweight | $15.00→ $18.00+20.0% |
|
Aug 06
00:29 UTC
|
BMY
Bristol Myers Squibb
|
↑ Upgrade | firm only | Market Perform→ Outperform | |
|
Aug 06
00:29 UTC
|
BMY
Bristol Myers Squibb
|
↑ Upgrade | Jasper Hellweg ★★★★☆ #697 | Hold→ Buy | $75.00 |
|
Aug 06
00:29 UTC
|
ADM
Archer Daniels Midland
|
↑ Upgrade | Steven K Haynes not yet tracked | Underweight→ Equal Weight | $60.00→ $79.00+31.7% |
|
Aug 06
00:29 UTC
|
ABBV
AbbVie
|
↑ Upgrade | firm only | Hold→ Buy | |
|
Aug 05
23:29 UTC
|
ZETA
Zeta Global
|
◎ Target | Clark Wright ★★★★★ #141 | Buy | $30.00→ $32.00+6.7% |
|
Aug 05
23:29 UTC
|
QLYS
Qualys
|
◎ Target | Rudy Kessinger ★★★★★ #159 | Neutral | $135.00→ $165.00+22.2% |
|
Aug 05
23:29 UTC
|
PINS
Pinterest
|
◎ Target | Wyatt Swanson ★★★☆☆ #1001 | Buy | $26.00→ $27.00+3.8% |
|
Aug 05
23:29 UTC
|
OSPN
Onespan
|
◎ Target | Rudy Kessinger ★★★★★ #159 | Neutral | $14.00→ $16.00+14.3% |
|
Aug 05
23:29 UTC
|
AMD
Advanced Micro Devices
|
◎ Target | Gil Luria ★★☆☆☆ #2491 | Buy | $425.00→ $550.00+29.4% |
|
Aug 05
22:29 UTC
|
WIX
Wix.com
|
◎ Target | Chris Zhang not yet tracked | Neutral | $58.00→ $66.00+13.8% |
|
Aug 05
22:29 UTC
|
TPG
TPG
|
◎ Target | Michael Brown ★★★★☆ #466 | Buy | $59.00→ $65.00+10.2% |
|
Aug 05
22:29 UTC
|
HLNE
Hamilton Lane
|
◎ Target | Michael Brown ★★★★☆ #466 | Buy | $114.00→ $131.00+14.9% |
|
Aug 05
22:29 UTC
|
EHTH
eHealth
|
◎ Target | Jonathan Yong ★☆☆☆☆ #3004 | Neutral | $2.00→ $1.75-12.5% |
|
Aug 05
22:29 UTC
|
DOCN
DigitalOcean
|
◎ Target | Radi Sultan ★★★★☆ #355 | Neutral | $155.00→ $140.00-9.7% |
|
Aug 05
22:29 UTC
|
CMI
Cummins
|
◎ Target | Steven Fisher ★★☆☆☆ #2660 | Buy | $850.00→ $835.00-1.8% |
|
Aug 05
22:29 UTC
|
CBT
Cabot
|
◎ Target | Joshua Spector ★★★☆☆ #1727 | Neutral | $97.00→ $92.00-5.2% |
|
Aug 05
22:29 UTC
|
BCC
Boise Cascade
|
◎ Target | Kurt Yinger ★★☆☆☆ #2336 | Buy | $92.00→ $99.00+7.6% |
|
Aug 05
22:29 UTC
|
APTV
Aptiv
|
◎ Target | Joseph Spak ★★★☆☆ #1858 | Buy | $80.00→ $62.00-22.5% |
|
Aug 05
22:29 UTC
|
APO
Apollo Global Management
|
◎ Target | Michael Brown ★★★★☆ #466 | Buy | $157.00→ $172.00+9.6% |
|
Aug 05
22:29 UTC
|
AME
AMETEK
|
◎ Target | Matt Summerville ★★☆☆☆ #2424 | Buy | $265.00→ $285.00+7.5% |
|
Aug 05
22:29 UTC
|
AGNT
Exp World
|
◎ Target | Tom White ★★☆☆☆ #2490 | Neutral | $6.50→ $4.75-26.9% |
|
Aug 05
22:29 UTC
|
LRLCY
L'Oreal
|
↑ Upgrade | firm only | Underperform→ Hold | |
|
Aug 05
21:28 UTC
|
URGN
Urogen Pharma
|
◎ Target | Tara Bancroft ★☆☆☆☆ #2985 | Buy | $50.00→ $60.00+20.0% |
|
Aug 05
21:28 UTC
|
ULS
UL Solutions
|
◎ Target | Joshua Chan ★★★☆☆ #1306 | Buy | $110.00→ $96.00-12.7% |
|
Aug 05
21:28 UTC
|
TMDX
TransMedics Group
|
◎ Target | Patrick Wood ★★★☆☆ #2229 | Neutral | $80.00→ $77.00-3.8% |
|
Aug 05
21:28 UTC
|
TDC
Teradata
|
◎ Target | Radi Sultan ★★★★☆ #355 | Neutral | $34.00→ $36.00+5.9% |
|
Aug 05
21:28 UTC
|
SYY
Sysco
|
◎ Target | Mark Carden ★★★☆☆ #1289 | Buy | $90.00→ $95.00+5.6% |
|
Aug 05
21:28 UTC
|
SNDR
Schneider National
|
◎ Target | Thomas Wadewitz ★★★☆☆ #1984 | Neutral | $27.00→ $34.00+25.9% |
|
Aug 05
21:28 UTC
|
KMB
Kimberly-Clark
|
◎ Target | Peter Grom ★★★★★ #270 | Neutral | $115.00→ $116.00+0.9% |
|
Aug 05
21:28 UTC
|
JELD
JELD-WEN
|
◎ Target | John Lovallo ★★★☆☆ #1823 | Neutral | $1.60→ $1.80+12.5% |
|
Aug 05
21:28 UTC
|
IT
Gartner
|
◎ Target | Joshua Chan ★★★☆☆ #1306 | Neutral | $164.00→ $196.00+19.5% |
|
Aug 05
21:28 UTC
|
INGR
Ingredion
|
◎ Target | Joshua Spector ★★★☆☆ #1727 | Neutral | $104.00→ $108.00+3.8% |
|
Aug 05
21:28 UTC
|
IDXX
IDEXX Laboratories
|
◎ Target | Andrea Alfonso ★★★★☆ #619 | Neutral | $620.00→ $670.00+8.1% |
|
Aug 05
21:28 UTC
|
IBTA
Ibotta
|
◎ Target | Chris Kuntarich ★★★☆☆ #1340 | Neutral | $30.00→ $38.00+26.7% |
|
Aug 05
21:28 UTC
|
GPOR
Gulfport Energy
|
◎ Target | Peyton Dorne ★★★★☆ #795 | Buy | $223.00→ $214.00-4.0% |
|
Aug 05
21:28 UTC
|
FRSH
Freshworks
|
◎ Target | Taylor McGinnis ★★★★★ #28 | Buy | $11.00→ $14.00+27.3% |
|
Aug 05
21:28 UTC
|
FLYW
Flywire
|
◎ Target | Timothy Chiodo ★★★★★ #254 | Neutral | $18.00→ $19.00+5.6% |
|
Aug 05
21:28 UTC
|
FBIN
Fortune Brands Innovations
|
◎ Target | John Lovallo ★★★☆☆ #1823 | Buy | $63.00→ $65.00+3.2% |
|
Aug 05
21:28 UTC
|
EXPD
Expeditors International of Washington
|
◎ Target | Thomas Wadewitz ★★★☆☆ #1984 | Buy | $191.00→ $210.00+9.9% |
|
Aug 05
21:28 UTC
|
ENTG
Entegris
|
◎ Target | Timothy Arcuri ★★☆☆☆ #2448 | Buy | $205.00→ $215.00+4.9% |
|
Aug 05
21:28 UTC
|
DD
DuPont de Nemours
|
◎ Target | Joshua Spector ★★★☆☆ #1727 | Buy | $175.00→ $178.00+1.7% |
|
Aug 05
21:28 UTC
|
CAT
Caterpillar
|
◎ Target | Steven Fisher ★★☆☆☆ #2660 | Neutral | $900.00→ $925.00+2.8% |
|
Aug 05
21:28 UTC
|
CACC
Credit Acceptance
|
◎ Target | Moshe Orenbuch ★★★★☆ #604 | Hold | $575.00→ $600.00+4.3% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.